InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.82
(
-0.11%
)
Bitcoin
60,339.34
(
0.29%
)
Post# of 34626
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

guydiamond

Send PM Follow Ignore
Followers 1
Posts 28
Boards Moderated 0
Alias Born 06/11/2019

guydiamond

Re: Eagle1 post# 27609

Saturday, 07/20/2019 11:15:09 AM

Saturday, July 20, 2019 11:15:09 AM

Post# of 34626
Someone posted about Halozyme therapeutics on stocktwits. I took a look at their product, and it does seem to have generated 3 CRs in pancreatic cancers from 60 patients, with an 85% response rate.

Would anybody be able to give their thoughts on comparison to Multitaa?

It looks like their product is mainly effective on HA-high tumors (25-30% of human tumors overexpress this, and this accumulation occurs in 87% of pancreatic tumors).

I know Multitaa is way more broadly applicable, but it seems like their product may be a significant treatment option for pancreatic cancer, and that may be an interesting point of comparison for multitaa results.

https://www.halozyme.com/investors/news-releases/news-release-details/2018/Halozyme-Provides-Summary-Results-Of-Data-For-PEGPH20-Combination-Treatments-Presented-At-ESMO-2018-Congress/default.aspx

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712709/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MRKR News
More MRKR News
InvestorsHub NewsWire

FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!